Intuitive Surgical, Inc. $ISRG Stock Sold by Keybank National Association OH

Keybank National Association OH trimmed its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.1% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 75,431 shares of the medical equipment provider’s stock after selling 3,223 shares during the period. Keybank National Association OH’s holdings in Intuitive Surgical were worth $30,673,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of ISRG. Fairscale Capital LLC grew its position in shares of Intuitive Surgical by 3.5% in the 3rd quarter. Fairscale Capital LLC now owns 645 shares of the medical equipment provider’s stock valued at $279,000 after buying an additional 22 shares during the last quarter. Beaumont Financial Advisors LLC increased its stake in shares of Intuitive Surgical by 3.8% in the third quarter. Beaumont Financial Advisors LLC now owns 627 shares of the medical equipment provider’s stock valued at $255,000 after buying an additional 23 shares during the period. Hughes Financial Services LLC raised its position in shares of Intuitive Surgical by 40.7% during the third quarter. Hughes Financial Services LLC now owns 83 shares of the medical equipment provider’s stock worth $37,000 after acquiring an additional 24 shares during the last quarter. W.G. Shaheen & Associates DBA Whitney & Co raised its position in shares of Intuitive Surgical by 1.0% during the first quarter. W.G. Shaheen & Associates DBA Whitney & Co now owns 2,542 shares of the medical equipment provider’s stock worth $1,172,000 after acquiring an additional 25 shares during the last quarter. Finally, Blue Fin Capital Inc. raised its position in shares of Intuitive Surgical by 0.5% during the first quarter. Blue Fin Capital Inc. now owns 4,794 shares of the medical equipment provider’s stock worth $2,210,000 after acquiring an additional 25 shares during the last quarter. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Stock Down 0.1%

NASDAQ ISRG opened at $449.53 on Thursday. Intuitive Surgical, Inc. has a 52 week low of $328.57 and a 52 week high of $603.88. The business has a 50 day moving average price of $414.76 and a 200-day moving average price of $430.83. The company has a market cap of $155.83 billion, a price-to-earnings ratio of 54.36, a P/E/G ratio of 3.10 and a beta of 1.45.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.65 by $0.35. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The company had revenue of $3.05 billion for the quarter, compared to analysts’ expectations of $2.91 billion. During the same period last year, the business earned $2.40 EPS. Intuitive Surgical’s quarterly revenue was up 21.7% compared to the same quarter last year. On average, equities research analysts anticipate that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on the company. Citigroup cut their price objective on Intuitive Surgical from $590.00 to $500.00 and set a “buy” rating on the stock in a research note on Friday, July 17th. TD Cowen reissued a “buy” rating and set a $485.00 target price on shares of Intuitive Surgical in a research report on Monday, October 19th. Wall Street Zen upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Saturday, October 31st. Sanford C. Bernstein restated an “outperform” rating on shares of Intuitive Surgical in a report on Wednesday, August 12th. Finally, HSBC downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating and set a $391.00 price target on the stock. in a research report on Thursday, July 30th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-three have given a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average target price of $493.54.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, SVP Patricia Wadors sold 1,078 shares of the company’s stock in a transaction on Friday, October 23rd. The shares were sold at an average price of $443.80, for a total transaction of $478,416.40. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Mark Brosius sold 61 shares of the firm’s stock in a transaction on Wednesday, October 28th. The shares were sold at an average price of $441.60, for a total transaction of $26,937.60. Following the completion of the transaction, the executive vice president directly owned 581 shares in the company, valued at $256,569.60. This trade represents a 9.50% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 39,056 shares of company stock worth $17,585,864 in the last ninety days. 0.60% of the stock is currently owned by corporate insiders.

About Intuitive Surgical

Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.